Source: IQVIA Formulary Impact Analyzer (FIA), National Prescription Audit, IQVIA Institute, Dec 2017
Chart notes: Total Retail dispensed prescriptions were factored by the sample of out-of-pocket cost information from Formulary Impact Analyzer. All payment types, included: commercial, Medicare, Medicaid and cash payments for the uninsured. Analysis also included brands and generics of all types of medicines including Specialty and Traditional were included.
Source -
Source +
While the majority of patients saw out-of-pocket costs below $10 for a prescription, that only represented 22% of total out-of-pocket costs.
0.2% of all prescriptions filled cost more than $250, but those prescriptions accounted for 9% of all out-of-pocket costs in the country. Overall, exposure to cost for patients varies considerably by insurance type and throughout the year—due to deductibles, the donut-hole and other cost-sharing mechanisms.
$1.18Bn
$1.88Bn
$1.0Bn
$57.8Bn
5,444Mn
$5.2Bn
0.2%
3.8 Mn
TRx
4.9 Mn
TRx
2.0 Mn
TRx
3.4 Mn
TRx
9.0
2.3%
14.5
5.9%
12.2
11.7%
9.6
48.9%
12.5
31.0%
$0
$0.01-$9.99
$10-$19.99
$20-$49.99
$50-$249.99
View Full Chart
Total
$250-$299
$300-$399
$400-$499
$500+
$250+
Out-of-Pocket Cost
Prescriptions
100%
75%
50%
25%
0%
Click the buttons to get more insights into the low and high end of the dispensed prescriptions and rollover the legend to compare prescriptions dispensed with out-of-pocket costs for patients.
Patients spent $57.8 billion in out-of-pocket costs for medicines in 2017 and their exposure to cost varied considerably